Hamburg: Breakthrough pathway can speed up drug approval, reduce costs

05/29/2014 | Bloomberg Businessweek

Food and Drug Administration Commissioner Margaret Hamburg said on Wednesday that the new approval program for breakthrough drugs may help reduce the cost of life-saving drugs by shortening the review process by years. "If we can lower the costs, we can lower the cost to patients ultimately. It really matters for patients, especially when there aren't other effective therapies in a given area," she said.

View Full Article in:

Bloomberg Businessweek

Published in Brief: